44 Additionally, anergic cells Commonly keep the next susceptibility to apoptosis Unless of course anti-apoptotic proteins such as BCL2 are overexpressed, as is the situation for CLL cells.forty five In fact, most significant therapeutic innovations developing in the final decade are related to the inhibition of BCR and BCL2-mediated signaling. https://nickn329fnv6.blogs100.com/profile